- Home
- SOS vs CRIS Comparison
SOS vs CRIS Comparison
Compare SOS & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOS
- CRIS
- Stock Information
- Founded
- SOS 2004
- CRIS 2000
- Country
- SOS China
- CRIS United States
- Employees
- SOS N/A
- CRIS N/A
- Industry
- SOS Finance: Consumer Services
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOS Finance
- CRIS Health Care
- Exchange
- SOS Nasdaq
- CRIS Nasdaq
- Market Cap
- SOS 14.8M
- CRIS 13.5M
- IPO Year
- SOS 2017
- CRIS 2000
- Fundamental
- Price
- SOS $5.63
- CRIS $1.98
- Analyst Decision
- SOS
- CRIS Strong Buy
- Analyst Count
- SOS 0
- CRIS 3
- Target Price
- SOS N/A
- CRIS $21.00
- AVG Volume (30 Days)
- SOS 21.6K
- CRIS 106.4K
- Earning Date
- SOS 01-01-0001
- CRIS 05-06-2025
- Dividend Yield
- SOS N/A
- CRIS N/A
- EPS Growth
- SOS N/A
- CRIS N/A
- EPS
- SOS N/A
- CRIS N/A
- Revenue
- SOS $111,124,000.00
- CRIS $11,202,000.00
- Revenue This Year
- SOS N/A
- CRIS $2.62
- Revenue Next Year
- SOS N/A
- CRIS $9.84
- P/E Ratio
- SOS N/A
- CRIS N/A
- Revenue Growth
- SOS N/A
- CRIS 14.17
- 52 Week Low
- SOS $4.04
- CRIS $1.02
- 52 Week High
- SOS $19.05
- CRIS $16.93
- Technical
- Relative Strength Index (RSI)
- SOS 56.58
- CRIS 52.24
- Support Level
- SOS $4.48
- CRIS $1.06
- Resistance Level
- SOS $7.51
- CRIS $2.45
- Average True Range (ATR)
- SOS 0.46
- CRIS 0.30
- MACD
- SOS 0.17
- CRIS 0.02
- Stochastic Oscillator
- SOS 38.94
- CRIS 36.19
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of big data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other service. The company has has three reporting segments: Commodity trading, Cryptocurrency mining and Others. Key revenue is generated from Commodity trading.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.